• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Nanotechnology in Drug Delivery: Global Markets Product Image

Nanotechnology in Drug Delivery: Global Markets

  • Published: January 2012
  • Region: Global
  • 121 Pages
  • Cientifica Ltd

This report focuses on NDD market opportunities in Asia, Europe, US and the RoW.

The report provides an in-depth presentation of recent developments (2000-2010) in nanoparticle-enabled DDS and future opportunities (2011-2021). Persons with a financial or academic interest in the pharmaceutical industry who want to learn how advances in nanotechnology research and development will impact the economics of the pharmaceutical market will benefit most from this report.

This report will focus on a geographical breakdown of the developed NDD TAM for the period 2000-2010, with a forecast NDD TAM for the period 2011-2021. The values are presented in $USD as well as percentages.

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialise. Cientifica's Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.

Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics READ MORE >

Executive Summary

Chapter 1
- Report Scope
- Thematic Scope
- Scope of Data Analysis
- Temporal Scope of Analysis
- Geographical Scope
- Report objective
- Methodology
- Calculation of CAGR
- The Nanoscale

Chapter 2
- Overview of nanotechnology
- What are the Key Drivers for Adoption of Nanotechnology in Medicine and Biomedicine?
- The Key Applications of Nanotechnology in Medicine and Biomedicine
- How Nanotechnology Can Benefit Drug Delivery
- How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector

Chapter 3
- Three Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine
- Five Current & Future Challenges in The Adoption of Nanotechnology in Medicine and Biomedicine

Chapter 4
- Global Market Analysis: 2000-2010 (Without Segmentation)
- Global Market Forecast: 2011-2021 (Without Segmentation)
- Market Analysis Countries and Regions: 2000-2010 (With Segmentation)
- Market Forecast Countries and Regions: 2011-2021 (With Segmentation)

Appendix
- Publishing activity by organization (2000-2010)

Table of Exhibits

Chapter One

Exhibit 1.1
Formula for the calculation of the Compound Annual Growth Rate (CAGR), (top).
Formula for the calculation of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.2
Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR), (top).
Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.3
Nanometres in a meter (top). Meters in a nanometre (bottom).

Chapter Two

Exhibit 2.1
The periodic table of elements, as we know it (at meter scale) is governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.

Exhibit 2.2
Proportion of the population aged over 65 and over 80 [7].

Exhibit 2.3
Illustration of a diagram of each property of nanocarriers (size, shape, surface chemistry and mechanical properties) and their parameters subjected to optimization in order to improve their efficiency [10].

Chapter Three

Exhibit 3.1
Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].

Exhibit 3.2
Illustration of the measures adoption roadmap to combat/attenuate the key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).

Exhibit 3.3
Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.4
Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.5
Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.6
Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.7
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.8
Bar chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Chapter Four:

Exhibit 4.8
Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, all countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.9
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures in percentage).

Exhibit 4.10
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.11
Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.12
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.13
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.14
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.15
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.16
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage)

Exhibit 4.17
Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.18
Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.19
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.20
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.21
3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.22
Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.23
Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.24
3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.25
3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.46
Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.47
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures in percentage).

Exhibit 4.48
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.49
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.50
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.51
3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.52
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.53
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.54
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.55
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.56
3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.57
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.58
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.59
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.60
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.61
3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.62
3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.63
Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.64
Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.65
3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.66
3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Appendix

Exhibit A.1
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.2
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.3
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.4
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.5
Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.
Organizations are ordered alphabetically (increasing order).

Exhibit A.6
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.7
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.8
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.9
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.10
Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.11
Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.
Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Nanotech Drug Delivery will be 15% of global nanotechnology market by 2021

Cientifica's latest report identifies China as fastest-growing sector

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialise. Cientifica's Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.

Cientifica's latest report, Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector, according to Cientifica.

“It’s a win-win situation for the nanotechnology and pharmaceutical industries,” said Tim Harper, CEO of Cientifica. “Drug delivery offers higher margins than other uses of nanomaterials, and allows manufacturers to access more of the value chain than if they were supplying materials for paint or sunscreen. At the same time, reformulation of drugs can enable the pharma industry to extend patents and hang on to existing revenue streams.”

Cientifica’s research indicates that global growth in the drug delivery market will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between now and 2021. China will be the largest market for nanotechnology based drug delivery systems by 2021, worth more than $18 billion and representing 43% of the Asian market.

France is forecast to surpass Japan as a drug delivery market within 10 years. Among European Union countries, the highest growth will be found in the former Eastern Bloc, and the lowest in the UK.

“While early ideas about the impact of nanotechnology on healthcare focussed on fanciful ideas involving small submarines and cancer-zapping robots, current advances have been enabled by advances in imaging, control over materials and an increased understanding of how biology works at the nanoscale,” said Harper

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos